PALLADINI, ARIANNA
PALLADINI, ARIANNA
DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC
2022 Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; Scalambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes
2022 Di Federico, Alessandro; De Giglio, Andrea; Gelsomino, Francesco; De Biase, Dario; Giunchi, Francesca; Palladini, Arianna; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea
Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies
2022 Andrini E.; Di Federico A.; Sisi M.; Rosellini M.; Palladini A.; Lamberti G.; De Giglio A.; Gelsomino F.
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine
2022 Ruzzi, Francesca; Palladini, Arianna; Clemmensen, Stine; Strøbæk, Anette; Buijs, Nicolaas; Domeyer, Tanja; Dorosz, Jerzy; Soroka, Vladislav; Grzadziela, Dagmara; Rasmussen, Christina Jo; Nielsen, Ida Busch; Soegaard, Max; Semprini, Maria Sofia; Scalambra, Laura; Angelicola, Stefania; Landuzzi, Lorena; Lollini, Pier-Luigi; Thorn, Mette
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft
2021 Landuzzi, Lorena; Palladini, Arianna; Ceccarelli, Claudio; Asioli, Sofia; Nicoletti, Giordano; Giusti, Veronica; Ruzzi, Francesca; Ianzano, Marianna L; Scalambra, Laura; Laranga, Roberta; Balboni, Tania; Arigoni, Maddalena; Olivero, Martina; Calogero, Raffaele A; De Giovanni, Carla; Dall'Ora, Massimiliano; Di Oto, Enrico; Santini, Donatella; Foschini, Maria Pia; Cucchi, Maria Cristina; Zanotti, Simone; Taffurelli, Mario; Nanni, Patrizia; Lollini, Pier-Luigi
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
2021 Giusti, Veronica; Ruzzi, Francesca; Landuzzi, Lorena; Ianzano, Marianna L; Laranga, Roberta; Nironi, Elena; Scalambra, Laura; Nicoletti, Giordano; De Giovanni, Carla; Olivero, Martina; Arigoni, Maddalena; Calogero, Raffaele; Nanni, Patrizia; Palladini, Arianna; Lollini, Pier-Luigi
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy
2021 De Giovanni, Carla; Landuzzi, Lorena; Palladini, Arianna; Nicoletti, Giordano; Nanni, Patrizia; Lollini, Pier-Luigi
IFN-γ and CD38 in Hyperprogressive Cancer Development
2021 Angelicola, Stefania; Ruzzi, Francesca; Landuzzi, Lorena; Scalambra, Laura; Gelsomino, Francesco; Ardizzoni, Andrea; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna
The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players?
2020 Lamberti G.; Sisi M.; Andrini E.; Palladini A.; Giunchi F.; Lollini P.-L.; Ardizzoni A.; Gelsomino F.
Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model
2019 De Giovanni, Carla; Nicoletti, Giordano; Landuzzi, Lorena; Palladini, Arianna; Lollini, Pier-Luigi; Nanni, Patrizia
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
2019 Nanni, Patrizia; Landuzzi, Lorena; Manara, Maria Cristina; Righi, Alberto; Nicoletti, Giordano; Cristalli, Camilla; Pasello, Michela; Parra, Alessandro; Carrabotta, Marianna; Ferracin, Manuela; Palladini, Arianna; Ianzano, Marianna L; Giusti, Veronica; Ruzzi, Francesca; Magnani, Mauro; Donati, Davide Maria; Picci, Piero; Lollini, Pier-Luigi; Scotlandi, Katia
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
2019 De Giovanni, Carla; Landuzzi, Lorena; Palladini, Arianna; Ianzano, Marianna Lucia; Nicoletti, Giordano; Ruzzi, Francesca; Amici, Augusto; Croci, Stefania; Nanni, Patrizia; Lollini, Pier-Luigi
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis
2019 De Giovanni, Carla; Nanni, Patrizia; Landuzzi, Lorena; Ianzano, Marianna L; Nicoletti, Giordano; Croci, Stefania; Palladini, Arianna; Lollini, Pier-Luigi
Cancer immunoprevention: from mice to early clinical trials
2018 Palladini, Arianna; Landuzzi, Lorena; Lollini, Pier-Luigi; Nanni, Patrizia
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis
2018 Nanni, Patrizia; De Giovanni, Carla; Burocchi, Alessia; Nicoletti, Giordano; Landuzzi, Lorena; Palladini, Arianna; Ianzano, Marianna Lucia; Arioli, Ivano; Colombo, Mario P.; Lollini, Pier-Luigi
Virus-like particle display of HER2 induces potent anti-cancer responses
2018 Palladini, Arianna; Thrane, Susan; Janitzek, Christoph M.; Pihl, Jessica; Clemmensen, Stine B.; de Jongh, Willem Adriaan; Clausen, Thomas M.; Nicoletti, Giordano; Landuzzi, Lorena; Penichet, Manuel L.; Balboni, Tania; Ianzano, Marianna L.; Giusti, Veronica; Theander, Thor G.; Nielsen, Morten A.; Salanti, Ali; Lollini, Pier-Luigi; Nanni, Patrizia; Sander, Adam F.
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response
2017 Palladini, Arianna; Nicoletti, Giordano; Lamolinara, Alessia; Dall'Ora, Massimiliano; Balboni, Tania; Ianzano, Marianna L; Laranga, Roberta; Landuzzi, Lorena; Giusti, Veronica; Ceccarelli, Claudio; Santini, Donatella; Taffurelli, Mario; Di Oto, Enrico; Asioli, Sofia; Amici, Augusto; Pupa, Serenella M; De Giovanni, Carla; Tagliabue, Elda; Iezzi, Manuela; Nanni, Patrizia; Lollini, Pier-Luigi
Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer
2017 Castagnoli, L.; Ghedini, G.C.; Koschorke, A.; Triulzi, T.; Dugo, M.; Gasparini, P.; Casalini, P.; Palladini, A.; Iezzi, M.; Lamolinara, A.; Lollini, P.L.; Nanni, P.; Chiodoni, C.; Tagliabue, E.; Pupa, S.M
Evaluation of metastatic burden and recovery of human metastatic cells from a mouse model
2016 Landuzzi, Lorena; Palladini, Arianna; Ianzano, Marianna Lucia; Laranga, Roberta; D’Intino, Giulia; Nanni, Patrizia; Lollini, Pierluigi
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis
2015 Croci, S.; Nanni, P.; Palladini, A.; Nicoletti, G.; Grosso, V.; Benegiamo, G.; Landuzzi, L.; Lamolinara, A.; Ianzano, M.L.; Ranieri, D.; Dall'Ora, M.; Iezzi, M.; De Giovanni, C.; Lollini, P.-L.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC | Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; S...calambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna | 2022-01-01 | TRANSLATIONAL LUNG CANCER RESEARCH | - | 1.01 Articolo in rivista | ADK-VR2 TLCR.pdf; tlcr-11-11-2216-coif.zip |
| Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes | Di Federico, Alessandro; De Giglio, Andrea; Gelsomino, Francesco; De Biase, Dario; Giunchi, Franc...esca; Palladini, Arianna; Sperandi, Francesca; Melotti, Barbara; Ardizzoni, Andrea | 2022-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-14-03472-v2.pdf; cancers-14-03472-s001.zip |
| Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies | Andrini E.; Di Federico A.; Sisi M.; Rosellini M.; Palladini A.; Lamberti G.; De Giglio A.; Gelso...mino F. | 2022-01-01 | IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine | Ruzzi, Francesca; Palladini, Arianna; Clemmensen, Stine; Strøbæk, Anette; Buijs, Nicolaas; Domeye...r, Tanja; Dorosz, Jerzy; Soroka, Vladislav; Grzadziela, Dagmara; Rasmussen, Christina Jo; Nielsen, Ida Busch; Soegaard, Max; Semprini, Maria Sofia; Scalambra, Laura; Angelicola, Stefania; Landuzzi, Lorena; Lollini, Pier-Luigi; Thorn, Mette | 2022-01-01 | BIOMEDICINES | - | 1.01 Articolo in rivista | biomedicines-10-02654-v2.pdf; biomedicines-10-02654-s001.zip |
| Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft | Landuzzi, Lorena; Palladini, Arianna; Ceccarelli, Claudio; Asioli, Sofia; Nicoletti, Giordano; Gi...usti, Veronica; Ruzzi, Francesca; Ianzano, Marianna L; Scalambra, Laura; Laranga, Roberta; Balboni, Tania; Arigoni, Maddalena; Olivero, Martina; Calogero, Raffaele A; De Giovanni, Carla; Dall'Ora, Massimiliano; Di Oto, Enrico; Santini, Donatella; Foschini, Maria Pia; Cucchi, Maria Cristina; Zanotti, Simone; Taffurelli, Mario; Nanni, Patrizia; Lollini, Pier-Luigi | 2021-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | PDX Breast Sci Rep small.pdf |
| Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression | Giusti, Veronica; Ruzzi, Francesca; Landuzzi, Lorena; Ianzano, Marianna L; Laranga, Roberta; Niro...ni, Elena; Scalambra, Laura; Nicoletti, Giordano; De Giovanni, Carla; Olivero, Martina; Arigoni, Maddalena; Calogero, Raffaele; Nanni, Patrizia; Palladini, Arianna; Lollini, Pier-Luigi | 2021-01-01 | ONCOGENESIS | - | 1.01 Articolo in rivista | HER-2 loss Oncogenesis.pdf; 41389_2021_360_MOESM1_ESM.pdf |
| HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy | De Giovanni, Carla; Landuzzi, Lorena; Palladini, Arianna; Nicoletti, Giordano; Nanni, Patrizia; L...ollini, Pier-Luigi | 2021-01-01 | CELLS | - | 1.01 Articolo in rivista | Rhabdo HER review Cells.pdf |
| IFN-γ and CD38 in Hyperprogressive Cancer Development | Angelicola, Stefania; Ruzzi, Francesca; Landuzzi, Lorena; Scalambra, Laura; Gelsomino, Francesco;... Ardizzoni, Andrea; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | CD38 cancers-13-00309-v2.pdf |
| The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players? | Lamberti G.; Sisi M.; Andrini E.; Palladini A.; Giunchi F.; Lollini P.-L.; Ardizzoni A.; Gelsomin...o F. | 2020-01-01 | CANCERS | - | 1.01 Articolo in rivista | Lamberti_PDL1_cancers-12-03129.pdf |
| Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model | De Giovanni, Carla; Nicoletti, Giordano; Landuzzi, Lorena; Palladini, Arianna; Lollini, Pier-Luig...i; Nanni, Patrizia | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | TSA cancers w suppl.pdf; cancers-11-01889-s001.zip |
| Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations | Nanni, Patrizia; Landuzzi, Lorena; Manara, Maria Cristina; Righi, Alberto; Nicoletti, Giordano; C...ristalli, Camilla; Pasello, Michela; Parra, Alessandro; Carrabotta, Marianna; Ferracin, Manuela; Palladini, Arianna; Ianzano, Marianna L; Giusti, Veronica; Ruzzi, Francesca; Magnani, Mauro; Donati, Davide Maria; Picci, Piero; Lollini, Pier-Luigi; Scotlandi, Katia | 2019-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | PDX bone Sci Rep.pdf |
| Cancer Vaccines Co-Targeting HER2/Neu and IGF1R | De Giovanni, Carla; Landuzzi, Lorena; Palladini, Arianna; Ianzano, Marianna Lucia; Nicoletti, Gio...rdano; Ruzzi, Francesca; Amici, Augusto; Croci, Stefania; Nanni, Patrizia; Lollini, Pier-Luigi | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | IGF1R vax Cancers-11-00517 (1).pdf; cancers-11-00517-s001.pdf |
| Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis | De Giovanni, Carla; Nanni, Patrizia; Landuzzi, Lorena; Ianzano, Marianna L; Nicoletti, Giordano; ...Croci, Stefania; Palladini, Arianna; Lollini, Pier-Luigi | 2019-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | Giovanni_et_al-2019-BMC_Cancer.pdf |
| Cancer immunoprevention: from mice to early clinical trials | Palladini, Arianna; Landuzzi, Lorena; Lollini, Pier-Luigi; Nanni, Patrizia | 2018-01-01 | BMC IMMUNOLOGY | - | 1.01 Articolo in rivista | Immunoprevention BMC Immunology.pdf |
| OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis | Nanni, Patrizia; De Giovanni, Carla; Burocchi, Alessia; Nicoletti, Giordano; Landuzzi, Lorena; Pa...lladini, Arianna; Ianzano, Marianna Lucia; Arioli, Ivano; Colombo, Mario P.; Lollini, Pier-Luigi | 2018-01-01 | ONCOIMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| Virus-like particle display of HER2 induces potent anti-cancer responses | Palladini, Arianna; Thrane, Susan; Janitzek, Christoph M.; Pihl, Jessica; Clemmensen, Stine B.; d...e Jongh, Willem Adriaan; Clausen, Thomas M.; Nicoletti, Giordano; Landuzzi, Lorena; Penichet, Manuel L.; Balboni, Tania; Ianzano, Marianna L.; Giusti, Veronica; Theander, Thor G.; Nielsen, Morten A.; Salanti, Ali; Lollini, Pier-Luigi; Nanni, Patrizia; Sander, Adam F. | 2018-01-01 | ONCOIMMUNOLOGY | - | 1.01 Articolo in rivista | HER2-VLP OncoImmunology.pdf; koni-07-03-1408749-s001.zip |
| HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response | Palladini, Arianna; Nicoletti, Giordano; Lamolinara, Alessia; Dall'Ora, Massimiliano; Balboni, Ta...nia; Ianzano, Marianna L; Laranga, Roberta; Landuzzi, Lorena; Giusti, Veronica; Ceccarelli, Claudio; Santini, Donatella; Taffurelli, Mario; Di Oto, Enrico; Asioli, Sofia; Amici, Augusto; Pupa, Serenella M; De Giovanni, Carla; Tagliabue, Elda; Iezzi, Manuela; Nanni, Patrizia; Lollini, Pier-Luigi | 2017-01-01 | ONCOTARGET | - | 1.01 Articolo in rivista | - |
| Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer | Castagnoli, L.; Ghedini, G.C.; Koschorke, A.; Triulzi, T.; Dugo, M.; Gasparini, P.; Casalini, P.;... Palladini, A.; Iezzi, M.; Lamolinara, A.; Lollini, P.L.; Nanni, P.; Chiodoni, C.; Tagliabue, E.; Pupa, S.M | 2017-01-01 | ONCOGENE | - | 1.01 Articolo in rivista | Castagnoli Oncogene 2016338a.pdf; onc2016338x5.zip |
| Evaluation of metastatic burden and recovery of human metastatic cells from a mouse model | Landuzzi, Lorena; Palladini, Arianna; Ianzano, Marianna Lucia; Laranga, Roberta; D’Intino, Giulia...; Nanni, Patrizia; Lollini, Pierluigi | 2016-01-01 | MACS & MORE | - | 1.01 Articolo in rivista | - |
| Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis | Croci, S.; Nanni, P.; Palladini, A.; Nicoletti, G.; Grosso, V.; Benegiamo, G.; Landuzzi, L.; Lamo...linara, A.; Ianzano, M.L.; Ranieri, D.; Dall'Ora, M.; Iezzi, M.; De Giovanni, C.; Lollini, P.-L. | 2015-01-01 | BREAST CANCER RESEARCH | - | 1.01 Articolo in rivista | IL-15 Breast Cancer Res.pdf; Additional files.zip |